- Home
- ORIC vs ATRO Comparison
ORIC vs ATRO Comparison
Compare ORIC & ATRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORIC
- ATRO
- Stock Information
- Founded
- ORIC 2014
- ATRO 1968
- Country
- ORIC United States
- ATRO United States
- Employees
- ORIC N/A
- ATRO N/A
- Industry
- ORIC Biotechnology: Pharmaceutical Preparations
- ATRO Military/Government/Technical
- Sector
- ORIC Health Care
- ATRO Industrials
- Exchange
- ORIC Nasdaq
- ATRO Nasdaq
- Market Cap
- ORIC 974.1M
- ATRO 1.2B
- IPO Year
- ORIC 2020
- ATRO N/A
- Fundamental
- Price
- ORIC $10.90
- ATRO $40.15
- Analyst Decision
- ORIC Strong Buy
- ATRO Strong Buy
- Analyst Count
- ORIC 10
- ATRO 1
- Target Price
- ORIC $17.33
- ATRO $49.00
- AVG Volume (30 Days)
- ORIC 895.7K
- ATRO 1.1M
- Earning Date
- ORIC 11-11-2025
- ATRO 11-05-2025
- Dividend Yield
- ORIC N/A
- ATRO N/A
- EPS Growth
- ORIC N/A
- ATRO N/A
- EPS
- ORIC N/A
- ATRO N/A
- Revenue
- ORIC N/A
- ATRO $822,852,000.00
- Revenue This Year
- ORIC N/A
- ATRO $9.05
- Revenue Next Year
- ORIC N/A
- ATRO $6.88
- P/E Ratio
- ORIC N/A
- ATRO N/A
- Revenue Growth
- ORIC N/A
- ATRO 10.99
- 52 Week Low
- ORIC $3.90
- ATRO $14.13
- 52 Week High
- ORIC $14.67
- ATRO $46.61
- Technical
- Relative Strength Index (RSI)
- ORIC 58.48
- ATRO 53.10
- Support Level
- ORIC $10.36
- ATRO N/A
- Resistance Level
- ORIC $11.16
- ATRO $46.61
- Average True Range (ATR)
- ORIC 0.51
- ATRO 2.01
- MACD
- ORIC 0.06
- ATRO -1.26
- Stochastic Oscillator
- ORIC 74.31
- ATRO 86.14
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
About ATRO Astronics Corporation
Astronics Corp supplies products to the aerospace, defense, and electronics industries. The company has two reportable segments namely Aerospace and Test Systems. The aerospace segment serves three primary markets: military, commercial transport, and General Aviation. The Test Systems segment serves the aerospace, defense, and semiconductor markets. The company generates a majority of its revenue from the Aerospace segment. Geographically, it generates a majority of its revenue from the United States.